Estabrook Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14
| Closed | -$12 | – | 351 |
|
|
2019
Q4 | $12 | Hold |
14
| – | – | ﹤0.01% | 342 |
|
|
2019
Q3 | $8 | Hold |
14
| – | – | ﹤0.01% | 331 |
|
|
2019
Q2 | $7 | Hold |
14
| – | – | ﹤0.01% | 321 |
|
|
2019
Q1 | $6 | Hold |
14
| – | – | ﹤0.01% | 333 |
|
|
2018
Q4 | $7 | Hold |
14
| – | – | ﹤0.01% | 337 |
|
|
2018
Q3 | $7 | Hold |
14
| – | – | ﹤0.01% | 358 |
|
|
2018
Q2 | $7 | Hold |
14
| – | – | ﹤0.01% | 363 |
|
|
2018
Q1 | $6 | Hold |
14
| – | – | ﹤0.01% | 369 |
|
|
2017
Q4 | $5 | Hold |
14
| – | – | ﹤0.01% | 375 |
|
|
2017
Q3 | $5 | Hold |
14
| – | – | ﹤0.01% | 398 |
|
|
2017
Q2 | $5 | Hold |
14
| – | – | ﹤0.01% | 400 |
|
|
2017
Q1 | $6 | Hold |
14
| – | – | ﹤0.01% | 406 |
|
|
2016
Q4 | $5 | Hold |
14
| – | – | ﹤0.01% | 445 |
|
|
2016
Q3 | $4 | Hold |
14
| – | – | ﹤0.01% | 416 |
|
|
2016
Q2 | $3 | Hold |
14
| – | – | ﹤0.01% | 431 |
|
|
2016
Q1 | $2 | Hold |
14
| – | – | ﹤0.01% | 443 |
|
|
2015
Q4 | $2 | Hold |
14
| – | – | ﹤0.01% | 451 |
|
|
2015
Q3 | $3 | Hold |
14
| – | – | ﹤0.01% | 459 |
|
|
2015
Q2 | $10 | Hold |
14
| – | – | ﹤0.01% | 451 |
|
|
2015
Q1 | $9 | Hold |
14
| – | – | ﹤0.01% | 458 |
|
|
2014
Q4 | $11 | Hold |
14
| – | – | ﹤0.01% | 465 |
|
|
2014
Q3 | $7 | Hold |
14
| – | – | ﹤0.01% | 464 |
|
|
2014
Q2 | $7 | Hold |
14
| – | – | ﹤0.01% | 465 |
|
|
2014
Q1 | $4 | Hold |
14
| – | – | ﹤0.01% | 465 |
|
|
2013
Q4 | $5 | Hold |
14
| – | – | ﹤0.01% | 471 |
|
|
2013
Q3 | $28 | Hold |
14
| – | – | ﹤0.01% | 466 |
|
|
2013
Q2 | $27 | Buy |
+14
| New | +$25 | ﹤0.01% | 472 |
|
Estabrook Capital Management's GCVRZ Position: Q1 2020 in Review
Estabrook Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 14 shares — an estimated $12 sold.
Estabrook Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $28 in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Estabrook Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Estabrook Capital Management sold 14 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $12.
- Estabrook Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Estabrook Capital Management's Sanofi Contingent Value Rights position peaked at $28 in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Estabrook Capital Management's 13F filing for Q1 2020, filed 14 May 2020.